 Patients who have a current diagnosis of mild-moderate dementia and suspected of having Alzheimers disease AD along with cognitively normal age-matched controls will be recruited for this study. The Alzheimers subjects either will have had a complete clinical and neuropsychiatric workup or will have those tests performed during the study. 